Jindal Drugs Pvt Ltd

Next 500 2015
OVERVIEW
FINANCIALS

Featured In Fortune India Ranking

Next 500 India
#335(2015)
#335(2015)

Financial Data 2020

Revenue
406
(INR Cr)
Net Operating Income
314
(INR Cr)
Assets
1,403
(INR Cr)
Profit
90
(INR Cr)
Net Worth
1,207
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS202020192018201720162015201420132012201120102009
Revenue
(INR Cr)
406
6.6%
381
-27.7%
527
65.3%
319
-6.8%
342
-65.1%
979
0.2%
978
-0.3%
981
-14.3%
1144
153.7%
451
-20.1%
564
49.6%
377
-
Net Operating Income
(INR Cr)
314
-7.59%
340
-15.13%
400
25.45%
319
2.62%
311
-64.11%
873
-7.12%
940
0.00%
955
-13.27%
1101
165.86%
414
-22.70%
536
47.29%
364
-46.69%
Profit
(INR Cr)
90
-19.0%
111
-23.6%
145
258.3%
41
-0.5%
41
-22.5%
53
-44.5%
95
-18.3%
116
64.4%
71
237.2%
21
-54.5%
46
84.2%
25
-
Assets
(INR Cr)
1403
20.8%
1161
3.1%
1126
29.7%
869
-22.3%
1119
2.9%
1087
5.9%
1026
24.1%
827
24.2%
666
14.2%
583
0.8%
578
26.3%
458
-
Net Worth
(INR Cr)
1207
8.1%
1116
11.0%
1006
16.9%
860
-10.4%
960
17.0%
941
8.3%
868
0.0%
673
20.8%
557
14.5%
486
4.5%
465
11.0%
419
5.2%
Employee Cost
(INR Cr)
6
-2.8%
6
10.2%
6
240.7%
2
129.3%
1
-96.2%
19
-5.4%
21
175.1%
7
51.4%
5
59.9%
3
10.0%
3
-13.8%
3
-
Interest Cost
(INR Cr)
523246211136210
Cash & Bank Balance
(INR Cr)
7575883891732293810121720524121492
Total Debt
(INR Cr)
1964412081581431551521089711339

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS202020192018201720162015201420132012201120102009
Profit As % Of Revenues 22.1%29.2%27.6%12.7%11.9%5.4%9.7%11.8%6.2%4.6%8.1%6.6%
Profit As % Of Assets 6.4%9.6%12.9%4.7%3.7%4.8%9.2%14.0%10.6%3.6%7.9%5.5%
Profit As % Of Networth 7.5%9.9%14.5%4.7%4.3%5.6%10.9%17.3%12.7%4.3%9.9%6.0%
Interest Cost to EBITDA % 7.4%1.8%3.3%7.2%8.4%12.4%15.2%8.1%33.0%40.0%3.5%-
Debt to Equity Ratio 0.160.040.120.010.160.150.180.230.190.200.240.09
RONW 7.7%10.5%14.0%4.5%4.0%5.8%10.9%18.9%13.5%4.4%9.9%6.1%
ROCE 9.7%12.7%17.0%5.0%4.3%6.8%13.7%21.1%19.8%5.0%9.7%5.6%